Objective: To discuss ethical and legal issues arisingfrom research conducted onforensic psychiatric patients. Method: A review ofthe literature and ethical and legal guidelines related to research ethics with human subjects. Conclusion: Forensic patients who are research subjects are particularly vulnerable to coercion and abuse as a result ofthe dual vulnerabilities stemmingfrom their status as both prisoners andpsychiatric patients. Researchers in the area offorensic mental health must carefully consider ethical guidelines and ensure that the rights ofparticipants are respected and upheld. (Can J Psychiatry 2000;45:892-898)
neurological evaluation ordered by the review board revealed no abnormalities.
At the review board hearing in 1990, the research department at the hospital indicated that the patient met the criteria for psychopathy as measured by the Psychopathy Checklist (PCL) (1). He had been scored on the instrument via a chart review pursuant to a contract with the Ministry of Health-described as both a research and a program initiative-to score all forensic patients in Ontario. The research resulted in the development of the Statistical Risk Appraisal Guide (SRAG) (2) , which was later refined to become the Sex Offender Risk Assessment Guide (SORAG) (3) and the Violence Risk Appraisal Guide (VRAG) (4) . These instruments relied on static historical factors for the prediction of a broad range ofviolent behaviour. Contrary to the instructions in the manual accompanying the PCL-R, the patient was not interviewed as part of the assessment (5) . Further, the patient was not informed that the study was being carried out, nor was he given the opportunity to consent or refuse participation. The hospital staff relied on the findings ofthe test to confirm their diagnosis and make their recommendations to the board.
In 1992, the board ordered that the patient be transferred to a medium security facility. Soon after the patient's arrival atthe new facility, the hospital received a SRAG (2) prepared by the research staff of the original hospital. Their research placed the patient in the highest category ofrisk for a community violent reoffense. It was suggested that among mentally disordered offenders, 100% of individuals in this category would reoffend within 7 years of release.
On the basis of the SRAG score and despite all other clinical andobservational data, the hospital staffat the new facility refusedto allow the patient to leave the locked ward without the direct supervision of an escort. The treatment team took the position that there was no scientific evidence available that would allow them to assess whether his risk had reduced over the 14 years of his treatment. They noted that the actuarial guide for the SRAG does not allow for attenuation by such dynamic factors as a favourable response to treatment or the patient's cooperation and good behaviour (all of which were documented without contradiction).
In 1999, counsel for the patient challenged the hospital's position.After an independent assessment using more advanced techniques, evidence of significant frontal perfusion deficits was elicited on single photon emission computed tomography (SPECT). Magnetic resonance imaging (MRI) showed dilation of the frontal horns of the lateral ventricles of the brain, while computerized electoencephalography showed increased slow-wave activity in both the frontal and temporal areasofthe brain. This clinical picture was clearly that ofpersonality change due to neonatal asphyxia. At the same time, sexualsadism was ruled out as a factor. A clinical trial ofa serotonin reuptake inhibitor was successful in modifying the clinical features of this condition.
The opportunity for a serious examination of the SRAG was also taken. The administration ofthe PCL-R, the most powerful variant of the SRAG, without an interview, despite the availability of the patient, raised serious concerns. The PCL-R manual cautions that "As an individual's scores may have important consequences for his or her future, the absolutevalue is ofcritical importance. The potential for harm is considerable if the peL is used incorrectly" (5) . Counsel also questioned the participation of this patient without his knowledge or consent in a research project leading to the development of the SRAG-a clinical instrument that had a devastating effect on his life and liberty.
The preceding case highlights complex issues which arise in theinterface between clinical management, legal disposition, and research with forensic patients. This paper reviews the historical development of research ethics with human subjects and discusses specific issues related to prisoners and psychiatric patients. Following this, we return to the case example and discuss the implications of research ethics for patients involuntarily detained because they pose a risk to society.
Historical Developments of Research Ethics
Thefirst code ofethics for research with human subjects emanated from the famous Doctors' Trial which took place in Nuremberg between 1947 and 1949. This trial focused on the Nazi doctors' experiments on prisoners in concentration camps-experiments that included exposure to extreme cold, high altitudes, mustard gas, sulfanilamide, sea water, and incendiary bombs (6) . In referring to the trial, US Chief Prosecutor Justice Robert Jackson stated "The wrongs which we seek to condemn and punish have been so calculated, so malignant, and so devastating, that civilization cannot tolerate their being ignored because it cannot survive their being repeated" (7, p 30-1). In the end, 16 doctors were found guilty of crimes against humanity, and 7 were sentenced to death by hanging (6) . The Trial resulted in the "Nuremberg Code," a list of 10 principles for research with human subjects. These principles include directives that research should seek societal good and minimize harm, that researchers must be scientifically competent, and most important, that voluntary consent is absolutely essential (8) .
The Nuremberg trial focused on the most heinous of crimes committed in the name ofresearch and created the impression that they were committed by monsters under the control of a totalitarian regime. It has, however, been argued that although in the Allied countries no physician researchers sank to the depths of the experimenters in Dachau or Auschwitz, many did act in violation ofthe principles defined in the Nuremberg Code, both during World War II and long after it ended (6) . Rothman chronicles the history of medical research in the US and cites numerous examples of flagrant abuses (9) . The first of these came to light in 1966 when Henry Beecher, a Harvard Medical School professor, wrote an expose in the New England Journal of Medicine (NEJM) (10) . The 22 examples cited by Beecher included a study published in the NEJM in which live hepatitis virus was injected into residents ofa state institution for the mentally retarded to allow researchers to study the etiology of the disease and attempt to create a vaccine (II). Another study involved injecting live cancer cells into elderly and senile hospitalized patients to study immune responses (12) . Beecher's conclusion was that unethical or questionably ethical procedures were not uncommon among researchers, and disregard for the rights of human subjects was widespread (9).
While we have, as Canadians, been for the most part immune from these exposes, many concerns about research in Canada have recently been raised as a result ofthe lawsuit of Dorothy Parker, one of 23 inmates involved with LSD experiments conducted between 1960 and 1963 at Kingston Prison for Women (13) . Pursuant to this case, Ms Parker's attorneys cited evidence that psychotropic drugs were also tested in Kingston Penitentiary in 1960, and in Collins Bay Prison in 1973. Moreover, they presented evidence ofabuses elswhere, including a 1964 letter wherein the federal government permitted researchers to give nightly steroid enemas for up to 3 weeks to inmates at Collins Bay Prison to assess whether rectal irritation occurred. Other examples of abuse included permission granted in 1972 to test penicillin on inmates in Quebec and a 1967 study in which the federal government used inmates to test the effects of ingesting pesticides. Canada' sjustice minister had decided in 1949 that consent from inmates was unnecessary for ECT experiments; however, by the early 1960s, Corrections Canada's policy was that consent was a prerequisite for scientific experiments (13) . The degree to which this consent is free and informed among involuntarily detained individuals nevertheless remains questionable.
Elements of Ethical Research Practice
In response to concerns about abuses committed in the name of research, there have been considerable efforts made to establish ethical principles and legal guidelines for research with human subjects. In 1944, following the lead of the Nuremberg Code, the World Medical Association adopted the Declaration ofHelsinki (most recently revised in 1989 [14] ). This declaration reinforced the importance ofsecuring voluntary consent, introduced a distinction between therapeutic and nontherapeutic research, and defined the role of proxy decision makers for those who could not give consent. In 1966, the United Nations General Assembly adopted the International Covenant on Civil and Political Rights (15) , and in 1993, the Council for International Organizations or Medical Sciences (CIOMS) published the International Ethical Guidelines for Biomedical Research Involving Human Subjects (16) . Currently, in the US, research with human subjects is guided by principles set out in the report by the National Commission for the Protection of Human Subjects of Biomedical and Behavioural Research (17) The primary emphasis ofmost human-subject research protocols is on protecting individual participants from suffering in the name ofresearch or knowledge-building (19) . The guidelines set out by all governing bodies, beginning with the International Covenant on Civil and Political Rights (15) emphasize 3 guiding principles: 1) respect for persons, which includes respect for autonomy and self-determination and the obligation to protect those with limited autonomy; 2) beneficence, which is both the ethical obligation to maximize benefits while minimizing harms and wrongs and the obligation to ensure that the research design is scientifically sound; and 3) justice, which entails the obligation to treat each person in accordance with what is morally right and proper and ensure an equitable distribution of burdens and benefits. Thus, these principles point to 2 important, yet potentially contradictory, levels of concern: individual rights and freedoms, and broader issues of benefit to mankind and society. It is often the conflict between these 2 levels of concern that leads to problems in the conduct ofethical research, particularly when related to individuals who are involuntarily detained.
Autonomy and SelfDetermination
Autonomy and self-determination are central features of research ethics and are codified in the doctrine of free and informed consent. Roberts and Roberts (8) identify 3 elements of informed consent: 1) communication of accurate and balanced information, 2) decisional capacity on the part of the participant, and 3) autonomy and absence of coercion.
To be informed, an individual must be provided with a candid and comprehensible summary of the procedures involved in the study. Only then can the subject weigh potential risks and benefits and make a meaningful choice. This duty to disclose information relevant to the choice that a patient is asked to make is codified in civil law regarding clinical procedures; it can lead to a finding of negligence if a patient's choice is inadequately informed and if the procedure results in adverse consequences (20) . Further, required information includes safeguards taken to ensure confidentiality of material and anonymity of participants (18) . Finally, prior to consenting, participants must be informed about the possibility of commercialization of the research findings and the presence of any apparent, actual, or potential conflict of interest on the part of the researchers, their institutions, or sponsors (18) . Personal information is held to be an individual's property to be used for the purposes to which the individual has agreed; it does not become the collectors' property to use in any way they see fit (21) .
Conflict ofinterest is a particularly difficult issue in many aspects of medical research. For instance, in a recent study of 2167 biomedical faculty in 50 universities, 43% reported receiving research gifts in the past 3 years, independent of grants or contracts. More than one-half of the donors expected something in return, leading recipients to report that donors placed restrictions and expected returns that were at times problematic for both the recipients and their institutions (22) . Further, while a conflict may be of a financial nature, other authors point out that conflicts can also include personal prestige, academic recognition, or promotion (23, 24) .
The second element ofinformed consent requires that an individual possess the mental capacity to understand the information provided and be able to weigh the risks and benefits. While the doctrine of informed consent serves well the interests of fully competent persons, it is argued that it falls short when applied to persons with compromised decision-making ability (25) . Both the Nuremberg Code and the International Covenant on Civil and Political Rights effectively prohibit nontherapeutic experimentation with persons who are unable to provide consent. In research with therapeutic benefits for individuals who cannot consent, researchers must follow appropriate protocols for consent from a substitute decision maker (17, 18) . These conditions suppose that the agent is acting according to the wishes of the patient and that the proposed intervention holds some benefit and minimal risk for the patient (26) . The issue ofcapacity for consent in psychiatric patients has recently been the subject of considerable debate (27) (28) (29) and will be addressed more fully later in this paper.
Finally, when an individual is informed and capable of weighing the risks and benefits, the researcher must ensure that consent is given freely and without coercion, that sufficient time and privacy are provided to allow the person to fully consider participation, and that the individual is free to refuse participation or withdraw from the study at any time (16, 18) . Roberts and Roberts (8) describe 3 sources ofvulnerability that may potentially undermine autonomy: 1) intrinsic vulnerability, which refers to attributes of the individual that limitfreedoms (such as age, intelligence, or psychosis); 2) extrinsic vulnerability, which refers to situational factors that limit freedoms (hospitalization, imprisonment, financial capacity); and 3) relational vulnerability, in which autonomy is limited by a relationship with the other person (teacher-student, doctor-patient).
Article 2.4 of the Tri-Council Statement identifies potential extrinsic and relational threats to autonomy or "voluntariness" that may take the form of inducement, deprivation, or exercise of control or authority over prospective subjects. "Voluntariness is especially relevant in research involving restricted or dependent subjects and is absent if consent is secured by the order of authorities or as a result of coercion or manipulation .... For example the voluntariness of prisoners, members of organizations with authoritarian structures (such as military, police, some religious groups or street gangs), or ofemployees or students may be restricted because their institutional context implies undue pressure" (18) . Further, the Declaration ofHelsinki (14) cautions that, when obtaining consent, the physician should be particularly cautious if the subject is in a dependent relationship with him or her because it may constitute duress.
In addition to ensuring that individuals will not be subject to negative consequences from others in a position of authority if they do not participate, the researcher must also ensure that inducements to participate do not undermine freedom to refuse. For example, individuals must not have access to treatment only ifenrolled in the study, and in addition, financial or other rewards cannot be so large that they induce the participation of those who would otherwise decline. Payments that undermine a person's capacity to exercise free choice invalidate consent (16): when large sums are offered as an inducement to participate, individuals may choose to endure suffering to which others in less desperate situations may not subject themselves. In addition, such individuals may conceal factors that would make them ineligible for participation and thereby subject themselves to additional risk (30) . Finally, individuals must have the right to withdraw from the study without prejudice to preexisting entitlements.
A possible exception to the imperative for consent occurs with the use of secondary data. In the past 2 decades, larger databases and newer techniques have improved researchers' capacity to evaluate service delivery and the outcomes of many procedures. The Tri-Council Policy Statement suggests that without access to public information it would be difficult, if not impossible, to conduct the important societal research that has led to major advances in knowledge and to improved quality oflife. Therefore, public interest may justify allowing researchers access to personal information in such sources as medical records, social service registries, and health and education databases. The Statement also notes that access to secondary data only becomes a concern when the data can be linked to individuals. Therefore, research ethics boards (REBs) are instructed to appraise carefully the possibility of identification and, in particular, the extent of harm or stigma that may be attached to identification.
Beneficence
Beneficence as an ethical obligation has 2 components: 1) the duty to do no harm (nonmaleficence) and 2) the duty to maximize possible benefits and minimize possible harms (31) . Biomedical research projects involving human subjects should be preceded by careful assessment ofpredictable risks compared with foreseeable benefits to the subject or others (14) . Harms and benefits to be considered go beyond physical harm alone to include psychological harm, legal harm, social harm, and economic harm (18, 31) . Further, the scientific validity of the design is included in the consideration of risks and benefits.The research must address a question of sufficient value to justify the risk posed to participants, it must follow the approved protocol, and findings must be reported accurately and promptly: shoddy science is never ethical (20) . Nonmaleficence requires that the investigator discontinue research if it is judged to be harmful to the individual participant.
Justice
While the concept of beneficence demands that the research is likely to bring about good through the advancement of scientific knowledge and that the benefits associated with the outcome are on balance greater than the potential risks to participants.justice focuses on the fair distribution ofburden and benefit. This principle addresses the protection of vulnerable individuals and groups who may be subject to research that will benefit society as a whole but who will not benefit directly. In stating that "In research on man, the interest of science and society should never take precedence over the considerations related to the well-being ofthe subject (14, III: 4) , the World Medical Association has underlined the principle that concern for the individual must always prevail over the interests ofsociety. In this regard, the scientist is bound by the same constraints as are ordinary citizens, in that worthy intentions do not justify violating a research subject's civil rights (21) . This principle is reinforced by such important medical journals as the NEJM, which has taken the position that it will not print reports of unethical work, regardless of scientific rigour or the value ofthe knowledge produced (32) . Nevertheless, opinion on this issue has not always been unanimous, and at times it appears that social benefits may have been viewed as legitimate exceptions to individual protections offered elsewhere. Bloomberg and Wilkins (21) quote the Institutional Guide to DHEWPolicy on Protection ofHuman Subjects, stating "The risks to an individual are [acceptable] if they are outweighed by the potential benefits to him [subject] or by the importance of knowledge to be gained."
Research Ethics with Forensic Patients
Psychiatric patients and prisoners are 2 populations that have been highlighted as having particular vulnerabilities with regard to voluntary participation in research. Forensic patients possess these dual vulnerabilities.
Prisoners
A"prisoner" is defined by the US Department of Health and Human Services as encompassing those individuals sentenced to institutions under criminal or civil statute, including individuals detained in facilities that provide alternatives to criminal prosecution or incarceration in a penal institution (33) . This definition includes patients in forensic mental health facilities. Prisoners have been identified as particularly vulnerable because their incarceration could affect their ability to make a truly voluntary and uncoerced decision whether to participate in research (34) . As a result, involvement ofvolunteer prisoners in biomedical research is permitted in very few countries (16) . In the US, as late as 1969, 85% of all new drugs were tested on prisoners in 42 prisons, but with the introduction of new federal guidelines, the percentage of drug testing in jails dropped to 15% by 1980. In 1976, the National Commission for the Protection of Human Subjects (17) concluded that prisoners were unable to give consent to drug research. The report declared that although prisoners who participate in research affirm that they do so freely, the conditions of social and economic deprivation in which they live compromise their freedom (35) . Consequently, research with prison populations has become very difficult to pursue, even when the population is particularly affected by the problem to be addressed (for example HIV) (36) .
The Belmont Report identifies the dilemma presented by competing claims urged by the principle of respect (17) . On one hand, respect for persons allows prisoners the opportunity to participate in research and exercise their right to consent; on the other hand, however, prison conditions may be such that they may be subtly coerced or unduly influenced. The Department of National Health (33) suggests that these issues should be weighed by institutional REBs. These boards are to comprise primarily individuals not associated with the institution, and 1 member must be a prisoner. The REB must consider whether any possible advantages accruing to the prisoner through participation are ofa magnitude to impair the prisoner's ability to weigh the risks ofthe research against the value of such advantages in the limited choice environment ofthe prison. Further, risks must be commensurate with those acceptable to nonprisoners. Finally, there must be adequate assurance that parole boards will not take into account a prisoner's participation and that the prisoner is clearly informed that participation in research will have no effect on his or her parole. Bloomberg and Wilkins add the suggestion that participation in research should be equivalent to a "Miranda warning"-that the arrestee must waive rights knowingly and voluntarily and with the explicit knowledge of how the information will be used (21) .
Psychiatric Patients
In 1993, a report by CIOMS called attention to concerns regarding research with psychiatric patients and their ability to offer informed consent (16) . This report stated that persons with mental health problems must not be the subjects of research that might equally be carried out on persons in full possession of their mental capacities; that the purpose of the research must be to obtain knowledge relevant to the particular health needs ofpersons with mental disorders; and finally, that consent must be obtained to the extent ofthe subject's capacities and that refusal to participate must always be respected. The 1998 report of the National Bioethics Advisory Commission further limited psychiatric research, causing some analysts to suggest that this effectively threatened all psychiatric research (8, 28) . The primary concern of committee members was the ability of psychiatric patients with impaired decision-making capacity to provide consent. Others argue, however, that dealing with subjects whose decisionmaking capacities may be impaired is not an issue unique to psychiatric research (27) . Empirical studies suggest that impaired decision making may be less serious for those with serious mental health problems, and more serious for those with physical health problems, than believed (28) . Nevertheless, a recent study ofthe decisional capacities ofinpatient psychiatric patients demonstrated substantial impairments in 52% of patients with schizophrenia and in 24% of subjects with depression, but the same impairments were demonstrated in only 12% of patients with medical problems (37) .
Ethical Issues Related to the Case Example
Asa forensic patient in a maximum-security psychiatric institution, the patient in the case example presented with vulnerabilities that could potentially undermine his capacity to give free and informed consent. This problem, however, was avoided by the researchers because subjects in the research project which led to the development of the SRAG were not approached for consent (38) . Rather, researchers collected secondary data from the medical records and phallometric assessments in the laboratory. When pressed on the issue of informedconsent at the board hearing, the response was that all patientsconsent to an assessment at the time ofthe incarceration, and therefore implied consent exists. Nevertheless, subjects consented with the understanding that the data were to be used for clinical purposes. Further, the voluntary element was questionable because release from involuntary detainment was contingent upon participation in treatment.
Canadian research ethics guidelines do allow for use of secondary data ifthe data are not linked to the subjects and the potentialrisk is low, and data used for research in that institutionwere routinely taken from clinical records "under anonymous conditions" (38 p 33). However, the SRAG instrument was later used on the patient and submitted as evidence in his review board hearing to demonstrate the supposed risk he posedto society. Consequently, the data were both linked and harmful in that it severely restricted his liberty.
A further issue is raised regarding the prediction of future criminal behaviour in forensic populations. The criterion in virtually every criminal justice prediction of recidivism impliesrestraint ofan individual by the state. Fairness is complicated by a power imbalance between the state and individuals. Errors can result in unjust lifelong deprivations ofliberty or, alternately, they can expose the public to serious loss or harm (39). Concerns have been expressed about the static factors employed by actuarial instruments, such as age at first offense, which admit no possibility of change outside the individual's control. According to the American Psychological Association, prediction of future criminal behaviour, if offered at all, should explicitly specify the acts being predicted, the estimated probability and associated time period of the acts, and finally, the basis of prediction (40) .
The preceding discussion suggests that 2 essential components of research ethics-informed consent and beneficence-may have been violated in the study that used the case patient as a subject. A final question arises as to whether the principle ofjustice justifies these violations. That is, does the aim of ensuring the safety of other members of society override concerns about the subject's individual rights and freedoms? To the general public, it may appear that prisoners, including forensic patients, do not have the same rights as free citizens because their treatment or punishment includes the Clinical Implications • Researchers must ensure that consent to treatment is not influenced by prior relationships with the patient or by undue inducement to participate.
• Researchers must clearly inform participants about possible longterm risks associated with participation in research.
• Researchers must ensure that the individual rights and freedoms of participants do not become secondary to the greater good ofsociety.
Limitations
• This is a selective, not comprehensive, review of the literature and legislation governing research ethics.
• Legislation and guidelines regarding research ethics are subject to change, and thus, this information is only current at the time of writing.
loss ofcertain civil rights (21) . Some authors have argued that informed consent and respect for autonomy are legitimately disregarded in some situations, such as clinical work or research with individuals who have committed sexual assaults or physical assaults against children (41, 42) . Such a stance may seem even more acceptable when a particular research project is aimed at protecting citizens from the subjects. Nevertheless, researchers are cautioned about using undemocratic means to meet important ends (19, 21) because similar arguments have justified unjust and damaging research against many vulnerable groups throughout history. Who society defines as morally inferior or threatening, and therefore unworthy of protection from injustice and harm, changes over time. Research that violates individual rights and freedoms creates a moral indignity and social harm (35) and is clearly contrary to established guidelines for ethical conduct (14) . Where research is allowed with prisoners, it is imperative that the benefits are as likely to be advantageous to the subject as to any alternative group (16) .
Conclusions
As a result ofhistoric injustices committed in the name of scientific advancement, organizations throughout the world have sought to establish principles to guide research with human subjects. The focus of these guidelines is to assure that individuals are safe from harm and are participating freely in research, with full knowledge ofits risks and benefits. Factors that undermine free consent include diminished capacity and institutional constraints. Psychiatric patients and prisoners are 2 populations that have been identified as particularly vulnerable in this regard. Forensic patients face the combined risks of both these vulnerable groups. As a result, researchers in the area of forensic mental health must carefully consider ethical guidelines and ensure that the rights ofparticipants are respected and upheld. 
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